Why Synthetic Biology Could Be An Internet-Level Investment Opportunity – And How To Play It
“This is what it might have been like 25 years ago if some guy had walked up to you and said the internet was going…
Biotech Buys: 2 Top Picks Under $10
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…
A Speculative Stock For What May Be “The Next Big Thing To Sweep Through Biotech”
The company discussed in today’s article is a potential leader in a burgeoning field that the author declares “has the potential to revolutionize medicine in…
A Lower-Risk Way To Play This “High-Octane” Healthcare Trend
A lower-risk way to play a “high-octane” healthcare trend is what the nine exchange-traded funds highlighted in today’s article offer. That trend? Biotechnology. And while…
While Biotech Underperformed In The First Half Of 2021, These Names Stood Out With Solid Gains
While biotech stocks underperformed the broader market in the first half of the year, some names – particularly those focused on neurodegenerative diseases and cancer…
Separating Promising Biotechs From The Most Promising Biotechs
“Today, I’m stepping in with an easy-to-use tool to help you find only the most compelling biotech stocks,” announces the author of today’s article. And…
“An Opportunity For Massive Profits”: 3 Top Stocks Under $10 A Share
“We are seeing an opportunity for massive profits in stocks under $10 a share,” declares the author of today’s article, who explains that “As so…
Casinos, The Cloud & Critical Infrastructure: 3 “Monster Growth Stocks” To Consider
A company that produces slot machines and provides financial equipment and services to casinos, a provider of cloud-based, business-critical communications and storage messaging services, and a broadband provider…
Beware These 10 Biopharma “High-Beta Bombs”
Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…
“Sizable Upside Potential”: 4 Aggressive Biotech And Life Sciences Plays Under $10
“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…